Business Context and Reporting Period
This Form 8-K filing by Harrow Health, Inc. (formerly Imprimis Pharmaceuticals, Inc.) covers the event date of December 27, 2018. The report details a corporate name change and the associated update to the company's stock trading symbol on The NASDAQ Capital Market.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding corporate governance changes and does not contain financial statement data.
Material Changes
- Corporate Name: Changed from "Imprimis Pharmaceuticals, Inc." to "Harrow Health, Inc." effective December 27, 2018.
- Trading Symbol: The ticker symbol on The NASDAQ Capital Market changed to "HROW".
- Stock Certificates: Existing stock certificates remain valid and do not require exchange, though shareholders may request updated certificates from the transfer agent.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, risks, contingencies, or unusual items. The document is strictly procedural regarding the amendment to the Restated Certificate of Incorporation.
Key Facts for Investors
- Verify the new ticker symbol "HROW" for trading purposes.
- Confirm that existing stock certificates remain valid without immediate action required.
- Note the company's new legal name is Harrow Health, Inc.
- Review the press release (Exhibit 99.1) for additional context on the strategic rationale for the name change.